Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a

Cover Page
  • Authors: Shcherbinin D.N.1, Esmagambetov I.B.1, Noskov A.N.1, Selyaninov Y.O.2, Tutykhina I.L.1, Shmarov M.M.1, Logunov D.Y.1, Naroditskiy B.S.1, Gintsburg A.L.1
  • Affiliations:
    1. Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation
    2. National Research Institute for Veterinary Virology and Microbiology of Russia
  • Issue: Vol 6, No 1 (2014)
  • Pages: 76-84
  • Section: Research Articles
  • URL: http://actanaturae.ru/2075-8251/article/view/10566
  • DOI: https://doi.org/10.32607/20758251-2014-6-1-76-84
  • Cite item

Abstract


Anthrax is a particularly dangerous infectious disease that affects humans and livestock. It is characterized by intoxication, serosanguineous skin lesions, development of lymph nodes and internal organs, and may manifest itsself in either a cutaneous or septic form. The pathogenic agent is Bacillus anthracis, a grampositive, endospore-forming, rod-shaped aerobic bacterium. Efficacious vaccines that can rapidly induce a long-term immune response are required to prevent anthrax infection in humans. In this study, we designed three recombinant human adenovirus serotype-5-based vectors containing various modifications of the fourth domain of the B. anthracis protective antigen (PA). Three PA modifications were constructed: a secretable form (Ad-sPA), a non-secretable form (Ad-cPA), and a form with the protective antigen fused to the Fc fragment of immunoglobulin G2a (Ad-PA-Fc). All these forms exhibited protective properties against Bacillus anthracis. The highest level of protection was induced by the Ad-PA-Fc recombinant adenovirus. Our findings indicate that the introduction of the Fc antibody fragment into the protective antigen significantly improves the protective properties of the Ad-PA-Fc adenovirus against B. anthracis.


D. N. Shcherbinin

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Author for correspondence.
Email: dim284@inbox.ru

Russian Federation

I. B. Esmagambetov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru

Russian Federation

A. N. Noskov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru

Russian Federation

Yu. O. Selyaninov

National Research Institute for Veterinary Virology and Microbiology of Russia

Email: dim284@inbox.ru

Russian Federation

I. L. Tutykhina

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru

Russian Federation

M. M. Shmarov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru

Russian Federation

D. Yu. Logunov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru

Russian Federation

B. S. Naroditskiy

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru

Russian Federation

A. L. Gintsburg

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru

Russian Federation

  1. Guichard A., Nizet V., Bier E. // Microbes Infect. 2012. V. 14. № 2. P. 97-118.
  2. Brachman P.S. // Ann. N.Y. Acad. Sci. 1980. № 353. P. 83-93.
  3. Davies J.C.A. // Central African J. Med. 1982. № 28. P. 291-298.
  4. Davies J.C.A. // Central African J. Med. 1983. № 29. P. 8-12.
  5. Davies J.C.A. // Central African J. Med. 1985. № 31. P. 176-180.
  6. Metcalfe N. // Occup. Med. 2004. V. 54. № 7. P. 489-493.
  7. Meaney-Delman D., Zotti M.E., Rasmussen S.A., Strasser S., Shadomy S., Turcios-Ruiz R.M., Wendel G.D., Treadwell T.A., Jamieson D.J., Gladus M.A., et al. // Obstet. Gynecol. Dec. 2012. V. 120. № 6. P. 1439-1449.
  8. Ipatenko N.G., Gavrilov V.A., Manichev A.A., Bastarov S.I., Salenko L.S., Yakovleva T.N., Stepanova V.V., Shmorgun B.I., Kiselev Yu.T., Sayitkhulov B.S. // Veterinary. 1995. № 5. С. 27-30.
  9. Auerbach S., Wright G.G. // J. Immunol. 1955. V. 75. № 2. P. 129-133.
  10. Broster M.G., Hibbs S.E. // Salisbury Med. Bull. Sp. Suppl. 1990. № 68. P. 91-92.
  11. Little S.F., Knudson G.B., Neidhardt F.C. // Ann. Meet. Amer. Soc. Microbiol. 1984. P. 46.
  12. Ward M.K., McGann V.G., Hogge A.L., Huff M.L., Kanode R.G., Roberts E.O. // J. Infect. Dis. 1965. № 115. P. 59-67.
  13. McConnell M.J., Hanna P.C., Imperiale M.J. // Infect. Immun. 2006. V. 74. № 2. P. 1009-1015.
  14. Tan Y., Hackett N.R., Boyer J.L., Crystal R.G. // Hum. Gene. Ther. 2003. V. 14. № 17. P. 1673-1682.
  15. Hashimoto M., Boyer J.L., Hackett N.R., Wilson J.M., Crystal R.G. // Infect. Immun. 2005. V. 73. № 10. P. 6885-6891.
  16. Yu Y.Z., Li N., Wang W.B., Wang S., Ma Y., Yu W.Y., Sun Z.W. // Vaccine. 2010. V. 28. № 47. P. 7529-7535.
  17. McConnell M.J., Hanna P.C., Imperiale M.J. // Mol. Ther. 2007. V. 15. № 1. P. 203-210.
  18. Shcherbinin D. N., Shmarov M.M., Naroditsky B.S., Rubakova E.I., Kondrateva T.K. // Tubercullosis and lung diseases. 2010. V. 87. № 10. P. 50-53.
  19. Shcherbinin D. N., Tutyhina I.L., Logunov D.U.,Shmarov M.M., Apt A.S., Kondrateva T.K. Naroditsky B.S. //Med. immunol. 2010. V. 13. № 4-5. P. 347.
  20. Sigalov A.B. // Adv. Exp. Med. Biol. 2008. № 640. P. 121-163.
  21. Graham D.B., Akilesh H.M., Gmyrek G.B., Piccio L., Gilfillan S., Sim J., Belizaire R., Carrero J.A., Wang Y., Blaufuss G.S., et al. // Blood. 2010. V. 116. № 17. P. 3208-3218.
  22. Walport M.J. // N. Engl. J. Med. 2001. V. 344. № 14. P. 1058-1066.
  23. Tutykhina I.L., Logunov D.Y., Shcherbinin D.N., Shmarov M.M., Tukhvatulin A.I., Naroditsky B.S., Gintsburg A.L. // J. Mol. Med. 2011. V. 89. № 4. P. 331-341.
  24. Zhang J., Jex E., Feng T., Sivko G.S., Baillie L.W., Goldman S., van Kampen K.R., Tang D.C. // Clin. Vaccine Immunol. 2013. V. 20. № 1. P. 1-8.
  25. Radjainia M., Hyun J.K., Leysath C.E., Leppla S.H., Mitra A.K. // Proc. Natl. Acad. Sci. USA. 2010. V. 107. № 32. P. 14070-14074.

Views

Abstract - 449

PDF (English) - 240

PDF (Russian) - 114

Cited-By


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2014 Shcherbinin D.N., Esmagambetov I.B., Noskov A.N., Selyaninov Y.O., Tutykhina I.L., Shmarov M.M., Logunov D.Y., Naroditskiy B.S., Gintsburg A.L.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies